BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34130108)

  • 21. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of some novel 1,2,3-triazole hybrids of myrrhanone B isolated from Commiphora mukul gum resin: Identification of potent antiproliferative leads active against prostate cancer cells (PC-3).
    Madasu C; Karri S; Sangaraju R; Sistla R; Uppuluri MV
    Eur J Med Chem; 2020 Feb; 188():111974. PubMed ID: 31883489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, molecular docking and anti-proliferative evaluations of [1,2,4]triazolo[4,3-a]quinoxaline derivatives as DNA intercalators and Topoisomerase II inhibitors.
    El-Adl K; El-Helby AA; Sakr H; Elwan A
    Bioorg Chem; 2020 Dec; 105():104399. PubMed ID: 33113414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Anticancer Activity of Triazole Linked Macrocycles and Heterocycles.
    Srinivas A; Rao EK
    Acta Chim Slov; 2021 Jun; 68(2):404-413. PubMed ID: 34738137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling.
    Hawash M; Abdallah S; Abudayyak M; Melhem Y; Abu Shamat M; Aghbar M; Çapan I; Abualhasan M; Kumar A; Kamiński M; Góral T; Dominiak PM; Sobuh S
    Eur J Med Chem; 2024 May; 271():116397. PubMed ID: 38626522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of novel 1,2,4-triazoles, triazolothiadiazines and triazolothiadiazoles as potential anticancer agents.
    Kamel MM; Megally Abdo NY
    Eur J Med Chem; 2014 Oct; 86():75-80. PubMed ID: 25147148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
    Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
    Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Biological Evaluation of New 1,2,3-Triazole Derivatives of the Chrysin Flavonoid as Anticancer Agents.
    Noole V; Krishna T; Godeshala S; Meraji S; Rege K; Reddy CK; Kedika B
    Anticancer Agents Med Chem; 2022; 22(1):160-168. PubMed ID: 33719963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterocyclization of 2-Arylidenecyclohexan-1,3-dione: Synthesis of Thiophene, Thiazole, and Isoxazole Derivatives with Potential Antitumor Activities.
    Abdo NYM; Mohareb RM; Al-Darkazali WN
    Anticancer Agents Med Chem; 2020; 20(3):335-345. PubMed ID: 31362693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of triazole linked glycosylated 18β-glycyrrhetinic acid derivatives as anticancer agents.
    Parida PK; Sau A; Ghosh T; Jana K; Biswas K; Raha S; Misra AK
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3865-8. PubMed ID: 25027936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
    Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
    J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
    Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
    Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
    Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.
    Kamal A; Shaik B; Nayak VL; Nagaraju B; Kapure JS; Shaheer Malik M; Shaik TB; Prasad B
    Bioorg Med Chem; 2014 Oct; 22(19):5155-67. PubMed ID: 25192811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors.
    El-Sherief HAM; Youssif BGM; Abbas Bukhari SN; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Eur J Med Chem; 2018 Aug; 156():774-789. PubMed ID: 30055463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, antitumor activity evaluation and mechanistic study of novel hederacolchiside A
    Li HN; Wang H; Wang ZP; Yan HN; Zhang M; Liu Y; Cheng MS
    Bioorg Med Chem; 2018 Aug; 26(14):4025-4033. PubMed ID: 29958763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents.
    Abolhasani H; Zarghi A; Komeili Movahhed T; Abolhasani A; Daraei B; Dastmalchi S
    Bioorg Med Chem; 2021 Feb; 32():115960. PubMed ID: 33477020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.